Y.-L., W., M., F., T.S.K., M., N., S., S., T., J.C.H., Y., . . . Y., R. (2014). Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study.

Y.-L., Wu, Fukuoka M., Mok T.S.K., Saijo N., Thongprasert S., Yang J.C.H., Chu D.-T., Yang J.-J., and Rukazenkov Y. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2014.

Y.-L., Wu, et al. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2014.